Special Issue on COVID-19 Research in Translational Metabolic Syndrome

Published 27 April, 2020

The urgent global quest for studies to prevent, mitigate or cure COVID-19 highlights to need for translation of medical and basic life science research into clinical practice. COVID-19 and host interactomes has presented patients with complicated clinical respiratory symptoms/characteristics, causing high mortality/fatality particularly among the patients with other underling medical conditions, such as hypertension, obesity, diabetes, and lipid disorders which are all the core elements with the clinical characteristics of metabolic syndrome.

Translational Metabolic Syndrome Research is the ideal journal to present the topics relevant to the above-mentioned studies from clinical diagnosis and treatment to social distancing, and community prevention and mitigation. 

All submissions will be subject to peer review and will receive prompt FREE publication upon formal acceptance. We encourage submissions of original research articles, reviews, case report and perspectives. Please visit our Instructions for Authors for more detailed submission instructions. 

Suggested topic areas include, but are not limited to:

  • COVID-19 Clinical Characteristics 
  • COVID-19 Motility and Comorbidly
  • COVID-19 Drug Repurposing
  • COVID-19 Diagnostics
  • COVID-19 Pathogenesis
  • COVID-19 Epidemiology and Spreading Prevention

Important Dates

All manuscripts should be submitted for consideration by 1 October 2020.

Back to Call for Papers

Stay Informed

Register your interest and receive email alerts tailored to your needs. Sign up below.